Daily FNArena News

The Chartist suggests recent consolidation for the iron ore price implies risk remains to the upside.

The New Criterion’s Tim Boreham notes massive legal settlements in the US have highlighted the scourge of opioid abuse, but Australian producer Palla Pharma is confident the drug class will remain the world’s foremost pain medication.

GUD Holdings has successfully coupled cost reductions with price rises and reiterates guidance for modest earnings growth in FY20.

Suncorp Group will sell two motor repair businesses to AMA Group, in a deal designed to improve utilisation of the repair shops while retaining a cost benefit.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

A glance through the latest expert views and predictions about commodities. Coal; iron ore; steel; base metals; and gold.

Pitt Street Research has revised its valuation range for MyFiziq.

Nufarm has addressed a vulnerable capital position with the sale of its South American crop protection business and investors can now focus on fundamentals.

Is US shale oil the key ingredient in the latest “oil shock” which puts the global oil market into surplus?

Michael Gable of Fairmont Equities notes Nearmap’s share price has stabilised and the stock may be setting for a recovery.